ANGIO-CONRAY Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Angio-conray, and what generic alternatives are available?
Angio-conray is a drug marketed by Mallinckrodt and is included in one NDA.
The generic ingredient in ANGIO-CONRAY is iothalamate sodium. There is one drug master file entry for this compound. Additional details are available on the iothalamate sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANGIO-CONRAY?
- What are the global sales for ANGIO-CONRAY?
- What is Average Wholesale Price for ANGIO-CONRAY?
Summary for ANGIO-CONRAY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 19 |
| Patent Applications: | 572 |
| DailyMed Link: | ANGIO-CONRAY at DailyMed |
US Patents and Regulatory Information for ANGIO-CONRAY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt | ANGIO-CONRAY | iothalamate sodium | INJECTABLE;INJECTION | 013319-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
